Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit

Hyderabad: Gosukonda Anji Reddy, 41, owner of Chandra Reddy Garden, and Gummadidala Swimming pool, in Gummadidala, and Kyasaram Rakesh, 36, a realtor, were arrested after a contraband manufacturing lab was discovered on their premises in Sangareddy.

The Telangana Anti-Narcotics Bureau (TGANB) officials seized 2.6 kilograms of contraband along with the manufacturing lab and the equipment used. About 20 kilograms of stage-1 intermediate product, 10 kilograms of stage-2 intermediate produce, 350 litres of mixed solution, 35 kilograms of hexamethyl antihistamine, 16 litres of acetic acid, one barrel of ammonium carbonate, and 90 kilograms of phosphorous penta sulphide were also seized.

According to officials, the two arrested were suppliers to a network of drugs comprising Prabhakar Goud and Sai Kumar, who were previously booked under the Narcotic Drugs and Psychotropic Substances (NDPS) Act for illegally manufacturing and selling alprazolam to toddy sellers for spiking the drink.

Sai Kumar Goud and K. Rakesh previously worked in various pharma laboratories and acquired knowledge of the chemicals and manufacturing process of alprazolam. Owing to the demand for adulterated toddy, they started manufacturing alprazolam illegally, the officials explained.

Five factories manufacturing alprazolam have been unearthed in the last one year including at Nagarkurnool DRI, Jinnaram, Cherlapally, Vijayawada and Fisalwadi – while the drug is also being supplied from Pune, Indore, Ratlam and Delhi.

A case has been booked under Section 8(c) r/w 21(c), 22(c), 29 of the NDPS Act-1985.

Related Posts

  • Pharma
  • June 24, 2025
  • 95 views
Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharmaceuticals announced that it had launched TEVIMBRA (tislelizumab) in India after receiving approval from the Central Drugs Standard Control Organization (CDSCO). The drug is a specially designed anti-PD-1 monoclonal…

  • Pharma
  • June 24, 2025
  • 104 views
India’s herbal and ayurvedic OTC market set to outpace global growth

New Delhi: India’s herbal and ayurvedic OTC (over the counter) market is expected to grow at a CAGR of 6.5 per cent, from $69 million in 2025 to $118 million…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma launches TEVIMBRA in India

Glenmark Pharma launches TEVIMBRA in India

India’s herbal and ayurvedic OTC market set to outpace global growth

India’s herbal and ayurvedic OTC market set to outpace global growth

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug